Nadja E Zorge, Johanna C van Huijstee, Jasper S Dijkema, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Errol P Prens, Hessel H van der Zee
{"title":"巴布亚新几内亚海湾省化脓性汗腺炎的流行情况。","authors":"Nadja E Zorge, Johanna C van Huijstee, Jasper S Dijkema, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Errol P Prens, Hessel H van der Zee","doi":"10.1159/000538422","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Hidradenitis suppurativa (HS) is a chronic and debilitating inflammatory skin disease, which mostly occurs in the skinfolds. The global prevalence of HS is currently unknown. Depending on the type of research and studied population, the reported prevalence varies between 0.03% and 4.1%. It is important to investigate the prevalence of HS worldwide using the same study design, in order to recognize, diagnose, and treat patients at an earlier stage. Consequently, a worldwide initiative, the Global Hidradenitis Suppurativa Atlas (GHiSA) has developed a study design to investigate the worldwide prevalence of HS in a comparable manner. The prevalence of HS in a Pacific Islander population has not been reported. The aim of this study was to estimate the prevalence of HS in Kapuna, Papua New Guinea.</p><p><strong>Methods: </strong>An explorative, descriptive, cross-sectional mono-center study in a secondary care center, the Kapuna Hospital, Papua New Guinea. Participants were healthy persons accompanying patients who were admitted to Kapuna Hospital or attending its Outpatient Department, and healthy hospital staff. The primary outcome of this study was the point prevalence of HS in Papua New Guinea using a validated questionnaire and physical examination.</p><p><strong>Results: </strong>A total of 520 participants were included in this study. The prevalence of HS in these 520 participants was 0.38% (2/520, 95% confidence interval 0.1-1.4%).</p><p><strong>Conclusion: </strong>The point prevalence of HS in Papua New Guinea was 0.38%. The findings of this study contribute to fill a gap in the current insights into global HS prevalence.</p>","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-6"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233960/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prevalence of Hidradenitis Suppurativa in the Gulf Province of Papua New Guinea.\",\"authors\":\"Nadja E Zorge, Johanna C van Huijstee, Jasper S Dijkema, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Errol P Prens, Hessel H van der Zee\",\"doi\":\"10.1159/000538422\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Hidradenitis suppurativa (HS) is a chronic and debilitating inflammatory skin disease, which mostly occurs in the skinfolds. The global prevalence of HS is currently unknown. Depending on the type of research and studied population, the reported prevalence varies between 0.03% and 4.1%. It is important to investigate the prevalence of HS worldwide using the same study design, in order to recognize, diagnose, and treat patients at an earlier stage. Consequently, a worldwide initiative, the Global Hidradenitis Suppurativa Atlas (GHiSA) has developed a study design to investigate the worldwide prevalence of HS in a comparable manner. The prevalence of HS in a Pacific Islander population has not been reported. The aim of this study was to estimate the prevalence of HS in Kapuna, Papua New Guinea.</p><p><strong>Methods: </strong>An explorative, descriptive, cross-sectional mono-center study in a secondary care center, the Kapuna Hospital, Papua New Guinea. Participants were healthy persons accompanying patients who were admitted to Kapuna Hospital or attending its Outpatient Department, and healthy hospital staff. The primary outcome of this study was the point prevalence of HS in Papua New Guinea using a validated questionnaire and physical examination.</p><p><strong>Results: </strong>A total of 520 participants were included in this study. The prevalence of HS in these 520 participants was 0.38% (2/520, 95% confidence interval 0.1-1.4%).</p><p><strong>Conclusion: </strong>The point prevalence of HS in Papua New Guinea was 0.38%. The findings of this study contribute to fill a gap in the current insights into global HS prevalence.</p>\",\"PeriodicalId\":11185,\"journal\":{\"name\":\"Dermatology\",\"volume\":\" \",\"pages\":\"1-6\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233960/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000538422\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000538422","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
Prevalence of Hidradenitis Suppurativa in the Gulf Province of Papua New Guinea.
Introduction: Hidradenitis suppurativa (HS) is a chronic and debilitating inflammatory skin disease, which mostly occurs in the skinfolds. The global prevalence of HS is currently unknown. Depending on the type of research and studied population, the reported prevalence varies between 0.03% and 4.1%. It is important to investigate the prevalence of HS worldwide using the same study design, in order to recognize, diagnose, and treat patients at an earlier stage. Consequently, a worldwide initiative, the Global Hidradenitis Suppurativa Atlas (GHiSA) has developed a study design to investigate the worldwide prevalence of HS in a comparable manner. The prevalence of HS in a Pacific Islander population has not been reported. The aim of this study was to estimate the prevalence of HS in Kapuna, Papua New Guinea.
Methods: An explorative, descriptive, cross-sectional mono-center study in a secondary care center, the Kapuna Hospital, Papua New Guinea. Participants were healthy persons accompanying patients who were admitted to Kapuna Hospital or attending its Outpatient Department, and healthy hospital staff. The primary outcome of this study was the point prevalence of HS in Papua New Guinea using a validated questionnaire and physical examination.
Results: A total of 520 participants were included in this study. The prevalence of HS in these 520 participants was 0.38% (2/520, 95% confidence interval 0.1-1.4%).
Conclusion: The point prevalence of HS in Papua New Guinea was 0.38%. The findings of this study contribute to fill a gap in the current insights into global HS prevalence.
期刊介绍:
Published since 1893, ''Dermatology'' provides a worldwide survey of clinical and investigative dermatology. Original papers report clinical and laboratory findings. In order to inform readers of the implications of recent research, editorials and reviews prepared by invited, internationally recognized scientists are regularly featured. In addition to original papers, the journal publishes rapid communications, short communications, and letters to ''Dermatology''. ''Dermatology'' answers the complete information needs of practitioners concerned with progress in research related to skin, clinical dermatology and therapy. The journal enjoys a high scientific reputation with a continually increasing impact factor and an equally high circulation.